Skip to main content
Caplight Logo









Illumigyn

Illumigyn

Private
IsraelHealthcare & Life Scienceshttps://www.illumigyn.com/

Last Round

Early Funding

Nov 3, 2021

Total Funding Raised

$38M

Company Overview

Illumigyn is a health tech company which has developed the Gynescope, an FDA-cleared remote gynecological imaging platform designed to improve diagnostic accuracy for women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Telemedicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

femtechtelehealthtelemedicineremote diagnosiscervical cancer screeninggynecological imagingdigital colposcopymedical devicewomen's healthmedical imagingcloud platformAI clinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Illumigyn Comparables

Compare Illumigyn with similar companies based on industry and business-model similarity.

Illumigyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Liger Medical
88%
Periwinkle Technologies
84%
GICMED
78%

Illumigyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 3, 2021
SeedJun 9, 2016

Illumigyn Investors

Notable investors and investment history

Illumigyn investors
InvestorRounds
Yozma Group KoreaEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 3, 2021

    $33M raised with Yozma Group Korea and Ubicom Holdings leading.

  • Jun 9, 2016

    Raised $5M with investors Ariel Katz and Ran Poliakine

Illumigyn Filings

Explore SEC and related filing metadata, where available.

Illumigyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Illumigyn's valuation, stock price, and market status.

Is Illumigyn a public or private company?

Illumigyn is a private company.

What is the current stock price of Illumigyn?

Illumigyn is a private company with no public stock price. No recent secondary market data is available.

How much is Illumigyn worth (valuation)?

Valuation information for Illumigyn is not publicly available.

Can I buy Illumigyn stock?

Illumigyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Illumigyn's last funding round?

Illumigyn's most recent funding round was Early Funding on November 3, 2021.

Who are the main investors in Illumigyn?

Key investors in Illumigyn include Yozma Group Korea.

Will Illumigyn IPO soon?

No public IPO plans have been announced for Illumigyn.

How can I track Illumigyn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Illumigyn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range11
Year Founded2012
Last FundingNov 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?